| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |